Aardvark Adventures Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Aardvark Adventures

DAVE 201.25

-1.7%

2:10 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: ~digs	3/31/2007 3:22:50 AM
	of 7944

AIS - Antares Pharma, Inc. operates as a specialty pharmaceutical product development and pipeline company worldwide. The company develops, produces, and markets various drug delivery platforms, including transdermal advanced transdermal delivery gels, fast-melt oral disintegrating tablets, disposable minineedle injection systems, and reusable needle-free injection systems. Tuesday March 27, 7:00 am ET Antares Pharma Reports Fourth Quarter and Year End 2006 Financial Results FDA Approves First Pharma Product and Record Revenues Recorded in Q4; Loss Narrows biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next